Perioperative Anticoagulant Management

Paul J. Grant, Daniel J. Brotman, Amir K. Jaffer

Research output: Contribution to journalReview article

Abstract

The oral anticoagulant warfarin is a common medication that requires special consideration in the perioperative period. Although some procedures do not require warfarin interruption, the majority will necessitate its temporary cessation due to the risk of bleeding. Determining whether patients will benefit from the temporary use of a heparin product while warfarin is discontinued perioperatively (so-called "bridging" therapy) needs to take into consideration the risk of bleeding balanced with the risk of thromboembolism. Perioperative care also requires minimizing the risk of venous thromboembolism (VTE). Understanding the patient-specific and procedure-specific risks for VTE is paramount to employ optimal risk reduction strategies. This article uses a case-based approach to present the topics of perioperative warfarin management and postoperative VTE prevention.

Original languageEnglish (US)
Pages (from-to)1105-1121
Number of pages17
JournalMedical Clinics of North America
Volume93
Issue number5
DOIs
StatePublished - Sep 1 2009

Keywords

  • Anticoagulation
  • Heparin
  • Perioperative care
  • Risk factors
  • Venous thromboembolism
  • Warfarin

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Perioperative Anticoagulant Management'. Together they form a unique fingerprint.

  • Cite this